Publication | Closed Access

YAP modifies cancer cell sensitivity to EGFR and survivin inhibitors and is negatively regulated by the non-receptor type protein tyrosine phosphatase 14

Tumor BiologySignal TransductionSignaling PathwaySurvivin InhibitorsMedicineReceptor Tyrosine KinaseYap Modifies CancerTumor SuppressorRadiation OncologyCancer BiologyCell BiologyCell SignalingCancer Research